Bank of America Forecasts Strong Price Appreciation for Ascendis Pharma A/S (NASDAQ:ASND) Stock
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price target hoisted by Bank of America from $201.00 to $216.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target suggests a potential upside of 25.33% from the company’s current […]
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price target hoisted by Bank of America from $201.00 to $216.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target suggests a potential upside of 25.33% from the company’s current […]
